I have been following MDR for a umber of months. Maybe someone here can help me out on their revenue model as I have been over a number of announcements and haven't really found any reference to how they derive their income stream.
Annually report suggests the made $1.43M through tap to refill. How does the company make its money. Is it through licenses, or per prescription refill.
$75M annualised prescription revenue through the platform and $1.43M sales revenue is less than 2% on sales throughput. Isn't this rather low?
Any help on the revenue models anyone can give me would be much appreciated.
Ann: MedAdvisor AGM CEO Presentation-MDR.AX, page-5
Add MDR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
50.0¢ |
Change
0.010(2.04%) |
Mkt cap ! $275.2M | |||
| Open | High | Low | Value | Volume |
| 49.0¢ | 50.0¢ | 48.0¢ | $244.9K | 498.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 49.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 50.0¢ | 335248 | 5 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| MDR (ASX) Chart |